Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics

Go back to Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
Xenetic Biosciences, Inc. (NASDAQ: XBIO) Delayed: 1.93 --0 (-0%)
Previous Close $1.93    52 Week High $5.20 
Open $1.93    52 Week Low $0.21 
Day High $1.93    P/E N/A 
Day Low $1.93    EPS $-0.01 
Volume 1